These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 9815902)
1. Expression of transforming growth factor beta and transforming growth factor beta receptors on AIDS-associated Kaposi's sarcoma. Ciernik IF; Krayenbühl Ciernik BH; Cockerell CJ; Minna JD; Gazdar AF; Carbone DP Clin Cancer Res; 1995 Oct; 1(10):1119-24. PubMed ID: 9815902 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-4 receptor expression in vivo on human AIDS-related Kaposi's sarcoma. Varricchio F; Husain SR; Leland P; Gill P; Puri RK Oncol Res; 1997; 9(9):495-503. PubMed ID: 9495455 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of transforming growth factor-beta 1 in Kaposi's sarcoma. Williams AO; Ward JM; Li JF; Jackson MA; Flanders KC Hum Pathol; 1995 May; 26(5):469-73. PubMed ID: 7750930 [TBL] [Abstract][Full Text] [Related]
4. Distribution of endoglin in early human development reveals high levels on endocardial cushion tissue mesenchyme during valve formation. Qu R; Silver MM; Letarte M Cell Tissue Res; 1998 May; 292(2):333-43. PubMed ID: 9560476 [TBL] [Abstract][Full Text] [Related]
5. Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. Brown LF; Dezube BJ; Tognazzi K; Dvorak HF; Yancopoulos GD Am J Pathol; 2000 Jun; 156(6):2179-83. PubMed ID: 10854238 [TBL] [Abstract][Full Text] [Related]
6. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Cai J; Gill PS; Masood R; Chandrasoma P; Jung B; Law RE; Radka SF Am J Pathol; 1994 Jul; 145(1):74-9. PubMed ID: 8030759 [TBL] [Abstract][Full Text] [Related]
7. TGF beta and FGF-like growth factors involved in the pathogenesis of AIDS-associated Kaposi's sarcoma. Roth WK Res Virol; 1993; 144(1):105-9. PubMed ID: 7680486 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. Samaniego F; Markham PD; Gallo RC; Ensoli B J Immunol; 1995 Apr; 154(7):3582-92. PubMed ID: 7897237 [TBL] [Abstract][Full Text] [Related]
9. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma. Furue M; Kato M; Nakamura K; Nashiro K; Kikuchi K; Okochi H; Miyazono K; Tamaki K Int J Cancer; 1997 May; 71(4):505-9. PubMed ID: 9178800 [TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids induce Kaposi's sarcoma cell proliferation through the regulation of transforming growth factor-beta. Cai J; Zheng T; Lotz M; Zhang Y; Masood R; Gill P Blood; 1997 Mar; 89(5):1491-500. PubMed ID: 9057628 [TBL] [Abstract][Full Text] [Related]
11. Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma. Bristow RE; Baldwin RL; Yamada SD; Korc M; Karlan BY Cancer; 1999 Feb; 85(3):658-68. PubMed ID: 10091739 [TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta 1 binding protein, TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms. Henriksen R; Gobl A; Wilander E; Oberg K; Miyazono K; Funa K Lab Invest; 1995 Aug; 73(2):213-20. PubMed ID: 7637321 [TBL] [Abstract][Full Text] [Related]
13. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma. Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004 [TBL] [Abstract][Full Text] [Related]
14. Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration. Ma X; Labinaz M; Goldstein J; Miller H; Keon WJ; Letarte M; O'Brien E Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2546-52. PubMed ID: 11116051 [TBL] [Abstract][Full Text] [Related]
15. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325 [TBL] [Abstract][Full Text] [Related]
17. Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma. Altomonte M; Montagner R; Fonsatti E; Colizzi F; Cattarossi I; Brasoveanu LI; Nicotra MR; Cattelan A; Natali PG; Maio M Br J Cancer; 1996 Nov; 74(10):1586-91. PubMed ID: 8932339 [TBL] [Abstract][Full Text] [Related]
18. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells. Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475 [TBL] [Abstract][Full Text] [Related]
19. Lack of expression of transforming growth factor-beta type II receptor associated with malignant progression in human salivary gland cell clones. Azuma M; Yuki T; Tamatani T; Motegi K; Yoshida H; Sato M Int J Cancer; 1996 Jun; 66(6):802-5. PubMed ID: 8647653 [TBL] [Abstract][Full Text] [Related]
20. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes. Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]